Mark op den Winkel

765 total citations
31 papers, 561 citations indexed

About

Mark op den Winkel is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Mark op den Winkel has authored 31 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 11 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Mark op den Winkel's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (5 papers). Mark op den Winkel is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (5 papers). Mark op den Winkel collaborates with scholars based in Germany, United States and Spain. Mark op den Winkel's co-authors include Alexander L. Gerbes, M Bilzer, Burkhard Göke, Christian J. Steib, Frank T. Kolligs, Rolf Schauer, Peter Fraunberger, Dorothea Nagel, Christoph Trumm and P Stieber and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Mark op den Winkel

27 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark op den Winkel Germany 13 335 217 168 91 86 31 561
Kazutoshi Okabe Japan 15 234 0.7× 247 1.1× 272 1.6× 70 0.8× 82 1.0× 43 707
Kazunori Ishige Japan 14 120 0.4× 238 1.1× 175 1.0× 61 0.7× 87 1.0× 34 639
Eisuke Kawamura Japan 6 521 1.6× 224 1.0× 326 1.9× 73 0.8× 69 0.8× 12 647
Zhenhua Tu China 9 209 0.6× 193 0.9× 144 0.9× 43 0.5× 35 0.4× 13 463
Sung W. Cho United States 11 219 0.7× 181 0.8× 368 2.2× 36 0.4× 86 1.0× 15 722
Takashi Kizu Japan 15 126 0.4× 206 0.9× 226 1.3× 48 0.5× 256 3.0× 26 664
Taizo Yamaguchi Japan 13 241 0.7× 117 0.5× 262 1.6× 83 0.9× 74 0.9× 22 544
Hajime Ohshiro Japan 15 184 0.5× 91 0.4× 286 1.7× 48 0.5× 74 0.9× 32 567
Nobuhiko Shimozawa Japan 13 460 1.4× 263 1.2× 342 2.0× 42 0.5× 109 1.3× 21 733
Sun‐Sang Wang Taiwan 12 261 0.8× 235 1.1× 71 0.4× 45 0.5× 32 0.4× 22 441

Countries citing papers authored by Mark op den Winkel

Since Specialization
Citations

This map shows the geographic impact of Mark op den Winkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark op den Winkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark op den Winkel more than expected).

Fields of papers citing papers by Mark op den Winkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark op den Winkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark op den Winkel. The network helps show where Mark op den Winkel may publish in the future.

Co-authorship network of co-authors of Mark op den Winkel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark op den Winkel. A scholar is included among the top collaborators of Mark op den Winkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark op den Winkel. Mark op den Winkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Barnikel, Michaela, Alessia Fraccaroli, Johanna Tischer, et al.. (2022). The Feasibility of Percutaneous Dilatational Tracheostomy in Immunosuppressed ICU Patients with or without Thrombocytopenia. Critical Care Research and Practice. 2022. 1–7. 4 indexed citations
3.
Reiter, Florian P., Najib Ben Khaled, Liangtao Ye, et al.. (2021). Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review. Digestive Diseases. 40(5). 565–580. 7 indexed citations
4.
Winkel, Mark op den, Jörg Schirra, Christian Schulz, et al.. (2021). Biliary Cannulation in Endoscopic Retrograde Cholangiography: How to Tackle the Difficult Papilla. Digestive Diseases. 40(1). 85–96. 13 indexed citations
5.
Kaiser, Rainer, Alexander Philipp, Julia Mayerle, et al.. (2020). Development of amoebic liver abscess in early pregnancy years after initial amoebic exposure: a case report. BMC Gastroenterology. 20(1). 424–424. 6 indexed citations
6.
Stecher, Stephanie-Susanne, Georg Beyer, Elisabetta Goni, et al.. (2018). Extracorporeal Membrane Oxygenation in Predominantly Leuco- and Thrombocytopenic Haematologic/Oncologic Patients with Acute Respiratory Distress Syndrome - a Single-Centre Experience. Oncology Research and Treatment. 41(9). 539–543. 13 indexed citations
7.
Koedel, Uwe, et al.. (2018). Impaired Consciousness in the Emergency Department. European Neurology. 80(3-4). 179–186. 17 indexed citations
8.
Winkel, Mark op den, Dorothea Nagel, Philipp M. Paprottka, et al.. (2018). The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma. Digestion. 100(1). 15–26. 3 indexed citations
9.
Winkel, Mark op den, Dorothea Nagel, Jörg Trojan, et al.. (2017). Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score. European Journal of Gastroenterology & Hepatology. 30(1). 44–53. 8 indexed citations
10.
Paprottka, Karolin J., Sebastian Lehner, Wolfgang P. Fendler, et al.. (2016). Reduced Periprocedural Analgesia After Replacement of Water for Injection with Glucose 5% Solution as the Infusion Medium for 90Y-Resin Microspheres. Journal of Nuclear Medicine. 57(11). 1679–1684. 13 indexed citations
11.
Schoenberg, Markus Bo, Sebastian Stintzing, Christoph Trumm, et al.. (2016). CyberKnife Radiosurgery – Value as an Adjunct to Surgical Treatment of HCC?. Cureus. 8(4). e591–e591. 2 indexed citations
12.
Reiter, Florian P., Clemens Gießen-Jung, Mario M. Dorostkar, et al.. (2015). Miliary pattern of brain metastases – a case report of a hyperacute onset in a patient with malignant melanoma documented by magnetic resonance imaging. Radiation Oncology. 10(1). 148–148. 3 indexed citations
13.
Schmidt, Laura S., et al.. (2014). Addition of Local Hepatic Therapy to Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Stage BCLC C). Digestion. 90(4). 219–228. 8 indexed citations
14.
Winkel, Mark op den, Julia Schewe, M Bilzer, et al.. (2013). Role of cysteinyl-leukotrienes for portal pressure regulation and liver damage in cholestatic rat livers. Laboratory Investigation. 93(12). 1288–1294. 8 indexed citations
15.
Winkel, Mark op den, Dorothea Nagel, R. Lamerz, et al.. (2012). Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort. PLoS ONE. 7(10). e45066–e45066. 54 indexed citations
16.
Nickel, Thomas, Michael Vogeser, Robert David, et al.. (2011). Extreme exercise enhances chromogranin A levels correlating with stress levels but not with cardiac burden. Atherosclerosis. 220(1). 219–222. 14 indexed citations
17.
Kolligs, Frank T., Mark op den Winkel, Christiane J. Bruns, et al.. (2010). Diagnose und multimodale Therapie des hepatozellulären Karzinoms. Zeitschrift für Gastroenterologie. 48(2). 274–288. 2 indexed citations
18.
Steib, Christian J., et al.. (2007). Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A2. Journal of Hepatology. 47(2). 228–238. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026